1.
Weiss J, Peifer M, Herling CD, Frenzel LP, Hallek M. Acquisition of the recurrent Gly101Val mutation in BCL2 confers resistance to venetoclax in patients with progressive chronic lymphocytic leukemia (Comment to Tausch et al.). Haematologica [Internet]. 2019Oct.30 [cited 2026Nov.16];104(11):e540-e540. Available from: https://haematologica.org/article/view/9149